Defense Health Board (DHB) Meeting, 8064 [E9-3767]

Download as PDF 8064 Federal Register / Vol. 74, No. 34 / Monday, February 23, 2009 / Notices high purity beryllium to the Department. Recognizing that high purity beryllium meets all the conditions for being a critical material, the Department should take, and has taken, special action to maintain a domestic supply. The Department has used the authorities of Title III of the Defense Production Act to contract with U.S. firm BrushWellman, Inc. to build and operate a new high purity beryllium production plant. The new facility will produce pure beryllium capable of meeting the specifications required for myriad national security applications. Dated: February 6, 2009. Patricia L. Toppings, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. E9–3708 Filed 2–20–09; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Defense Health Board (DHB) Meeting Department of Defense (DoD). Notice of meeting. AGENCY: ACTION: SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150, and in accordance with section 10(a)(2) of Public Law, the following meeting of the Defense Health Board (DHB) is announced. DATES: March 9–10, 2009. jlentini on PROD1PC65 with NOTICES March 9, 2009 7 a.m.–12 p.m. (Open Session). 12 p.m.–2:15 p.m. (Administrative Working Meeting). 2:15 p.m.–5:15 p.m. (Open Session). March 10, 2009 8 a.m.–4:30 p.m. (Administrative Working Meeting). ADDRESSES: Flagler Ballroom, Marriott Beachside Hotel, 3841 North Roosevelt Boulevard, Key West, Florida 33040. FOR FURTHER INFORMATION CONTACT: Commander Edmond F. Feeks, Executive Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg Pike, Suite 810, Falls Church, Virginia 22041–3206, (703) 681–8448, EXT. 1228, Fax: (703) 681–3317, edmond.feeks@tma.osd.mil. Additional information, agenda updates, and meeting registration are available online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb. The public is encouraged to register for the meeting. VerDate Nov<24>2008 16:31 Feb 20, 2009 Jkt 217001 If special accommodations are required to attend (sign language, wheelchair accessibility) please contact Ms. Lisa Jarrett at (703) 681–8448 ext. 1280 by February 27, 2009. Written statements may be mailed to the above address, emailed to dhb@ha.osd.mil or faxed to (703) 681–3317. SUPPLEMENTARY INFORMATION: Purpose of the Meeting: The purpose of the meeting is to address and deliberate pending and new Board issues and provide briefings for Board members on topics related to ongoing Board business. Agenda: On March 9, 2009, the Board will receive briefings on military operations worldwide and in the Key West, Florida area. The following Defense Health Board Subcommittees will present updates to the Board: the Department of Defense Joint Pathology Center Work Group, the Task Force on the Review of the Department of Defense Biological Research Portfolio and Biodefense Infrastructure, the Psychological Health External Advisory Subcommittee, the Trauma and Injury Subcommittee, the Health Care Delivery External Advisory Subcommittee, the National Capital Region Base Realignment and Closure Subcommittee, and the Traumatic Brain Injury Family Caregivers Panel. The Board will also receive an informational briefing on the use of apheresis platelets and fresh whole blood in trauma situations. The Board will conduct administrative sessions in concert with the meeting on March 9, 2009 and on March 10, 2009. Pursuant to 41 Code of Federal Regulations, Part 102–3.160, the administrative working meetings are closed to the public. Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165 and subject availability of space, the Defense Health Board meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on March 9, 2009 is open to the public. Any member of the public wishing to provide input to the Defense Health Board should submit a written statement in accordance with 41 CFR 102–3.140(C) and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice. Written statement should be not longer than two type-written pages and must address the following detail: The issue, discussion, and a recommended course of action. Supporting documentation may also be included as needed to establish the appropriate historical context and to provide any necessary background information. PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 Individuals desiring to submit a written statement may do so through the Board’s Designated Federal Officer at the address detailed above at any point. However, if the written statement is not received at least 10 calendar days prior to the meeting, which is subject to this notice, then it may not be provided to or considered by the Defense Health Board until the next open meeting. The Designated Federal Officer will review all timely submissions with the Defense Health Board Chairperson, and ensure they are provided to members of the Defense Health Board before the meeting that is subject to this notice. After reviewing the written comments, the Chairperson and the Designated Federal Officer may choose to invite the submitter of the comments to orally present their issue during an open portion of this meeting or at a future meeting. The Designated Federal Officer, in consultation with the Defense Health Board Chairperson, may, if desired, allot a specific amount of time for members of the public to present their issues for review and discussion by the Defense Health Board. Dated: February 17, 2009. Patricia L. Toppings, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. E9–3767 Filed 2–20–09; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID DOD–2009-OS–0025] Privacy Act of 1974; Systems of Records AGENCY: Defense Finance and Accounting Service, DoD. ACTION: Notice to Amend a System of Records. SUMMARY: The Defense Finance and Accounting Service (DFAS) is proposing to amend a system of records notice in its inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. DATES: This proposed action will be effective without further notice on March 25, 2009 unless comments are received which would result in a contrary determination. ADDRESSES: Send comments to the Defense Finance and Accounting Service, FOIA/PA Program Manager, Corporate Communications and Legislative Liaison, 8899 E. 56th Street, Indianapolis, IN 46249–0150. E:\FR\FM\23FEN1.SGM 23FEN1

Agencies

[Federal Register Volume 74, Number 34 (Monday, February 23, 2009)]
[Notices]
[Page 8064]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3767]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Health Board (DHB) Meeting

AGENCY: Department of Defense (DoD).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5 
U.S.C., Appendix as amended), the Sunshine in the Government Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in 
accordance with section 10(a)(2) of Public Law, the following meeting 
of the Defense Health Board (DHB) is announced.

DATES: March 9-10, 2009.

March 9, 2009

    7 a.m.-12 p.m. (Open Session).
    12 p.m.-2:15 p.m. (Administrative Working Meeting).
    2:15 p.m.-5:15 p.m. (Open Session).

March 10, 2009

    8 a.m.-4:30 p.m. (Administrative Working Meeting).

ADDRESSES: Flagler Ballroom, Marriott Beachside Hotel, 3841 North 
Roosevelt Boulevard, Key West, Florida 33040.

FOR FURTHER INFORMATION CONTACT: Commander Edmond F. Feeks, Executive 
Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg 
Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448, 
EXT. 1228, Fax: (703) 681-3317, edmond.feeks@tma.osd.mil. Additional 
information, agenda updates, and meeting registration are available 
online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb. 
The public is encouraged to register for the meeting. If special 
accommodations are required to attend (sign language, wheelchair 
accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext. 
1280 by February 27, 2009. Written statements may be mailed to the 
above address, e-mailed to dhb@ha.osd.mil or faxed to (703) 681-3317.

SUPPLEMENTARY INFORMATION:
    Purpose of the Meeting: The purpose of the meeting is to address 
and deliberate pending and new Board issues and provide briefings for 
Board members on topics related to ongoing Board business.
    Agenda: On March 9, 2009, the Board will receive briefings on 
military operations worldwide and in the Key West, Florida area. The 
following Defense Health Board Subcommittees will present updates to 
the Board: the Department of Defense Joint Pathology Center Work Group, 
the Task Force on the Review of the Department of Defense Biological 
Research Portfolio and Biodefense Infrastructure, the Psychological 
Health External Advisory Subcommittee, the Trauma and Injury 
Subcommittee, the Health Care Delivery External Advisory Subcommittee, 
the National Capital Region Base Realignment and Closure Subcommittee, 
and the Traumatic Brain Injury Family Caregivers Panel. The Board will 
also receive an informational briefing on the use of apheresis 
platelets and fresh whole blood in trauma situations. The Board will 
conduct administrative sessions in concert with the meeting on March 9, 
2009 and on March 10, 2009. Pursuant to 41 Code of Federal Regulations, 
Part 102-3.160, the administrative working meetings are closed to the 
public.
    Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 
102-3.165 and subject availability of space, the Defense Health Board 
meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on March 
9, 2009 is open to the public. Any member of the public wishing to 
provide input to the Defense Health Board should submit a written 
statement in accordance with 41 CFR 102-3.140(C) and section 10(a)(3) 
of the Federal Advisory Committee Act, and the procedures described in 
this notice. Written statement should be not longer than two type-
written pages and must address the following detail: The issue, 
discussion, and a recommended course of action. Supporting 
documentation may also be included as needed to establish the 
appropriate historical context and to provide any necessary background 
information.
    Individuals desiring to submit a written statement may do so 
through the Board's Designated Federal Officer at the address detailed 
above at any point. However, if the written statement is not received 
at least 10 calendar days prior to the meeting, which is subject to 
this notice, then it may not be provided to or considered by the 
Defense Health Board until the next open meeting.
    The Designated Federal Officer will review all timely submissions 
with the Defense Health Board Chairperson, and ensure they are provided 
to members of the Defense Health Board before the meeting that is 
subject to this notice. After reviewing the written comments, the 
Chairperson and the Designated Federal Officer may choose to invite the 
submitter of the comments to orally present their issue during an open 
portion of this meeting or at a future meeting.
    The Designated Federal Officer, in consultation with the Defense 
Health Board Chairperson, may, if desired, allot a specific amount of 
time for members of the public to present their issues for review and 
discussion by the Defense Health Board.

    Dated: February 17, 2009.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. E9-3767 Filed 2-20-09; 8:45 am]
BILLING CODE 5001-06-P